top of page
Pathways Panel
The Problem:
So far, success of precision medicine initiatives has been limited, why?
-
DNA-based, even though a DNA mutation does not imply downstream pathway activation
-
Focused only on one gene/one protein
-
Focused only on one molecular pathway
Our Solution:
A novel, multi-plexed, complementary diagnostic that integrates RNA and Protein information to determine pathway activation and identify the right targeted therapy for the right patient.
bottom of page